These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8272907)

  • 21. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.
    Pegues DA; Engelgau MM; Woernle CH
    Public Health Rep; 1994; 109(4):530-8. PubMed ID: 8041853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal screening for substance abuse at the time of parturition.
    Azadi A; Dildy GA
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalizations with amphetamine abuse among pregnant women.
    Cox S; Posner SF; Kourtis AP; Jamieson DJ
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):341-7. PubMed ID: 18238971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance use in rural Midwestern pregnant women.
    Yawn BP; Yawn RA; Uden DL
    Arch Fam Med; 1992 Sep; 1(1):83-8. PubMed ID: 1341592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anonymous cocaine screening in a private obstetric population.
    Burke MS; Roth D
    Obstet Gynecol; 1993 Mar; 81(3):354-6. PubMed ID: 8437785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time of birth.
    Roca Comas A; Vila Domènech JS; Massa Solé J; Timoneda Paz P; Peñas Boira M; Herrero Espinet FJ; Sánchez Jiménez J; Ballester Martínez A
    Minerva Pediatr; 2020 Feb; 72(1):37-44. PubMed ID: 28176511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.
    Oga EA; Mark K; Peters EN; Coleman-Cowger VH
    J Addict Med; 2020; 14(5):423-430. PubMed ID: 32032210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study.
    McCalla S; Minkoff HL; Feldman J; Delke I; Salwin M; Valencia G; Glass L
    Am J Obstet Gynecol; 1991 Feb; 164(2):625-30. PubMed ID: 1992714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of chemical substance and alcohol abuse in an obstetric population in Dublin.
    Bosio P; Keenan E; Gleeson R; Dorman A; Clarke T; Darling M; O'Connor J
    Ir Med J; 1997; 90(4):149-50. PubMed ID: 9267096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
    Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
    Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Drug Alcohol Depend; 2010 Jun; 109(1-3):243-7. PubMed ID: 20171023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR; Northrup TF; Villarreal YR; Berens PD; Blackwell S; Bunag T; Stotts AL
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence study of substance abuse in a midwestern city.
    Ware S; Liguori R; Jamerson P; Weiner V; Joubert-Jackson C
    J Pediatr Nurs; 1993 Jun; 8(3):152-8. PubMed ID: 8340880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of narcotics and street drugs during pregnancy.
    Lindsay MK; Burnett E
    Clin Obstet Gynecol; 2013 Mar; 56(1):133-41. PubMed ID: 23314719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF; Varner MW; Chase RA
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital.
    Keith LG; MacGregor S; Friedell S; Rosner M; Chasnoff IJ; Sciarra JJ
    Obstet Gynecol; 1989 May; 73(5 Pt 1):715-20. PubMed ID: 2704496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine and the pregnant woman.
    Nair BS; Watson RR
    J Reprod Med; 1991 Dec; 36(12):862-7. PubMed ID: 1816397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide practices for screening and reporting prenatal cocaine abuse: a survey of teaching programs.
    Pelham TL; DeJong AR
    Child Abuse Negl; 1992; 16(5):763-70. PubMed ID: 1393735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychoactive substance use during pregnancy: a review].
    Lamy S; Thibaut F
    Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.